The center will be co-financed by the Chengdu Municipal Government and will help the sustainable development of West-China’s manufacturing industry, urbanization and industrial economy. The new center will help to develop modern genome engineering, biotech drugs, high value fine chemicals, bio-based plastics, high-end health products, for the conversion of bio-industry core technology to the whole chain of industrial biotechnology products. As an operating entity, Chengdu Ketai Wo Biological Technology Ltd. ” will be headquartered in Chengdu’s Tianfu District at the Chengdu Science City construction site.”
CAS news release, August 19, 2016
CAS builds 2nd Industrial Biotechnology Center in Chengdu, partners with Tianjin Institute